Condition: Lymphoblastic Lymphoma, Childhood · Sponsor: University Hospital Muenster
Primary objectives: * Randomization R1, all patients eligible: To examine, whether the cumulative incidence of relapses with involvement of the CNS (CNS relapse, pCICR) can be decreased by a modified induction therapy including dexamethasone (experimental arm) instead of prednisone (standard arm) * Randomization R2, only patients with high risk LBL eligible: to examine, whether the probability of event-free survival (pEFS) in these patients can be improved by receiving an intensified treatment arm versus a standard treatment arm (as used in the EURO-LB 02)
This description comes directly from the study's public registry record.
Birgit Burkhardt, Prof. Dr. Dr. · +49 251 83 55696 · LBL2018@ukmuenster.de
Always discuss trial participation with your own doctor first.
| Univ.Klinik für Kinder- und Jugendheilkunde Graz, Klin. Abteilung für pädiatrische Hämato-Onkologie | Graz, Austria | Recruiting |
| Univ.Klinik für Kinder- und Jugendheilkunde Innsbruck, Universitätsklinik für Pädiatrie I | Innsbruck, Austria | Recruiting |
| Kepler Universitätsklinikum, Med Campus IV / Onkologie | Linz, Austria | Recruiting |
| LKH Salzburg, Universitätsklinik für Kinder- und Jugendheilkunde, Kinderonkologie | Salzburg, Austria | Recruiting |
| St. Anna Kinderspital | Vienna, Austria | Recruiting |
| Hôpital Universitaire des Enfants Reine Fabiola (ULB), Pédiatrie hémato-oncologie | Brussels, Belgium | Recruiting |
| University Hospital Brussels, Pediatrische oncologie | Brussels, Belgium | Recruiting |
| Cliniques Universitaires Saint-Luc (UCL), Hématologie et oncologie pédiatrique | Brussels, Belgium | Recruiting |
| UZ Antwerpen Kinderhemato-oncologie | Edegem, Belgium | Recruiting |
| University Hospital Gent Pediatrische hemato-oncologie | Ghent, Belgium | Recruiting |
| University Hospitals Leuven, Kinderhemato-oncologie | Leuven, Belgium | Recruiting |
| CHR Citadelle Hémato - oncologie pédiatrique | Liège, Belgium | Recruiting |
+ 216 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04043494